share_log

Anika Therapeutics Analyst Ratings

Benzinga ·  Aug 10, 2023 07:15
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/10/2023 13.97% Stephens & Co. $28 → $23 Maintains Equal-Weight
05/31/2023 38.75% Stephens & Co. → $28 Reiterates Equal-Weight → Equal-Weight
04/14/2023 38.75% Stephens & Co. → $28 Reiterates → Equal-Weight
03/07/2023 Barrington Research Downgrades Outperform → Market Perform
11/09/2022 53.62% Barrington Research → $31 Upgrades Market Perform → Outperform
10/14/2022 28.84% Stephens & Co. → $26 Reinstates → Equal-Weight
03/09/2022 Stephens & Co. Downgrades Overweight → Equal-Weight
11/16/2021 172.55% Stephens & Co. → $55 Initiates Coverage On → Overweight
07/16/2021 127.95% UBS → $46 Initiates Coverage On → Neutral
12/16/2020 113.08% Barrington Research → $43 Upgrades Market Perform → Outperform
01/21/2020 202.28% Sidoti & Co. → $61 Upgrades Neutral → Buy
11/05/2019 43.71% BWS Financial → $29 Initiates Coverage On → Sell
09/23/2019 First Analysis Downgrades Strong Buy → Outperform
02/22/2019 103.17% Sidoti & Co. $56 → $41 Downgrades Buy → Neutral

What is the target price for Anika Therapeutics (ANIK)?

The latest price target for Anika Therapeutics (NASDAQ: ANIK) was reported by Stephens & Co. on August 10, 2023. The analyst firm set a price target for $23.00 expecting ANIK to rise to within 12 months (a possible 13.97% upside). 6 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Anika Therapeutics (ANIK)?

The latest analyst rating for Anika Therapeutics (NASDAQ: ANIK) was provided by Stephens & Co., and Anika Therapeutics maintained their equal-weight rating.

When is the next analyst rating going to be posted or updated for Anika Therapeutics (ANIK)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Anika Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Anika Therapeutics was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.

Is the Analyst Rating Anika Therapeutics (ANIK) correct?

While ratings are subjective and will change, the latest Anika Therapeutics (ANIK) rating was a maintained with a price target of $28.00 to $23.00. The current price Anika Therapeutics (ANIK) is trading at is $20.18, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment